AMDA Pocket Guidelines

Dementia Depression Delirium

AMDA GUIDELINES App Bundle brought to you courtesy of AMDA and Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512442

Contents of this Issue

Navigation

Page 39 of 53

Appendices 40 Appendix A: Antipsychotic Agents Antipsychotic a Generic Name (Brand Name) Indications and Dosage Haloperidol (Haldol ® ) Psychosis: • Oral: 0.5 to 2 mg twice daily to three times daily (max: 20 mg/day) Agitation associated with dementia (off-label): • Oral: 0.25 to 2 mg daily; slowly increase dose based on tolerability every 4 to 7 days (max: 6 mg daily in 1 or 2 divided doses). Recommend AGAINST first-line use of haloperidol for non-emergent situations. If no response in 4 weeks, begin taper to discontinuation. Agitation associated with delirium (off-label): • Oral/IM: 0.5 to 2 mg once (for mild agitation). • 5 to 10 mg once (for severe agitation). • Repeat doses are based on clinical response. • IV (severe agitation only): 2 mg once, followed by repeat doses every 15 to 20 minutes while agitation persists. Once delirium is controlled, may repeat a dose every 4 to 6 hours. Olanzapine (Zyprexa ® ) Depression (in combination with fluoxetine): • Oral: 5 mg in the evening, titrate as tolerated. (max: 20 mg daily) Agitation associated with dementia (off-label): • Oral: 2.5 to 5 mg daily; increasing dose as tolerated (max: 10 mg daily) • IM: 2.5 to 5 mg as one dose; can repeat 1.25 or 2.5 mg dose up to 2 additional doses with at least 2 hours between doses (max: 12.5 mg per episode) • If no response in 4 weeks, begin taper to discontinuation. Agitation associated with delirium (off-label): • Oral: 5 mg daily for up to 5 days. For patients >60 years old, 2.5 mg daily for up to 5 days Pimavanserin (Nuplazid ® ) Parkinson Disease Psychosis: • Oral: 34 mg once daily

Articles in this issue

view archives of AMDA Pocket Guidelines - Dementia Depression Delirium